XML 82 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Data (unaudited)  
Schedule of Quarterly Financial Data (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

 

    

First Quarter

    

Second Quarter

    

Third Quarter

    

Fourth Quarter

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

6,306,712

 

$

8,223,783

 

$

(1,604,399)

¹

$

7,457,953

 

General and administrative

 

 

3,159,657

 

 

3,287,276

 

 

3,530,617

 

 

3,958,211

 

Total operating expenses

 

 

9,466,369

 

 

11,511,059

 

 

1,926,218

 

 

11,416,164

 

Loss from operations

 

 

(9,466,369)

 

 

(11,511,059)

 

 

(1,926,218)

 

 

(11,416,164)

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

350,951

 

 

439,201

 

 

436,846

 

 

295,140

 

Foreign exchange loss

 

 

(31,599)

 

 

(63,327)

 

 

(457,018)

 

 

406,033

 

Total other income (expense)

 

 

319,352

 

 

375,874

 

 

(20,172)

 

 

701,173

 

Net loss

 

$

(9,147,017)

 

$

(11,135,185)

 

$

(1,946,390)

 

$

(10,714,991)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share basic and diluted

 

$

(0.47)

 

$

(0.50)

 

$

(0.08)

 

$

(0.46)

 

Basic and diluted weighted average shares outstanding

 

 

19,452,088

 

 

22,116,758

 

 

23,186,410

 

 

23,191,428

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2018

 

 

    

First Quarter

    

Second Quarter

    

Third Quarter

    

Fourth Quarter

 

Revenue

 

$

 —

 

$

 —

 

$

 —

 

$

86,000

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

8,975,513

 

 

8,533,466

 

 

4,859,902

 

 

4,876,162

 

General and administrative

 

 

3,420,623

 

 

3,436,340

 

 

3,125,780

 

 

3,256,044

 

Total operating expenses

 

 

12,396,136

 

 

11,969,806

 

 

7,985,682

 

 

8,132,206

 

Loss from operations

 

 

(12,396,136)

 

 

(11,969,806)

 

 

(7,985,682)

 

 

(8,046,206)

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

175,184

 

 

186,304

 

 

278,214

 

 

321,621

 

Foreign exchange loss

 

 

(85,382)

 

 

(223,731)

 

 

(99,897)

 

 

(65,658)

 

Total other income (expense)

 

 

89,802

 

 

(37,427)

 

 

178,317

 

 

255,963

 

Net loss

 

$

(12,306,334)

 

$

(12,007,233)

 

$

(7,807,365)

 

$

(7,790,243)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share basic and diluted

 

$

(0.91)

 

$

(0.89)

 

$

(0.47)

 

$

(0.44)

 

Basic and diluted weighted average shares outstanding

 

 

13,467,694

 

 

13,504,485

 

 

16,587,353

 

 

17,616,373

 

 

(1)

During the three months ended September 30, 2019, the Company recorded $8.3 million as an incentive and tax receivable and recorded a corresponding credit to research and development expense for amounts expected to be received through the AOF for the period January 1, 2018 through September 30, 2019.